Ghisallo Capital Management LLC Ionis Pharmaceuticals Inc Transaction History
Ghisallo Capital Management LLC
- $913 Million
- Q4 2024
A detailed history of Ghisallo Capital Management LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Ghisallo Capital Management LLC holds 100,000 shares of IONS stock, worth $3.26 Million. This represents 0.38% of its overall portfolio holdings.
Number of Shares
100,000
Previous 400,000
75.0%
Holding current value
$3.26 Million
Previous $16 Million
78.18%
% of portfolio
0.38%
Previous 1.56%
Shares
2 transactions
Others Institutions Holding IONS
# of Institutions
412Shares Held
140MCall Options Held
829KPut Options Held
789K-
Vanguard Group Inc Valley Forge, PA16.5MShares$537 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$462 Million0.31% of portfolio
-
Capital World Investors Los Angeles, CA11.5MShares$374 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$336 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.67MShares$283 Million0.06% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.63B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...